Gannet BioChem, a leading specialty Contract Development and Manufacturing Organization (CDMO) backed by Boston-based private equity firm Ampersand Capital Partners, today announced the acquisition of ...

Gannet BioChem, a specialty Contract Development and Manufacturing Organization (CDMO) backed by Boston-based private equity ...

CRESSON, Texas--(BUSINESS WIRE)--Integrity BioChem, a technology-driven company developing next-generation biopolymers, was recognized at the 2021 ICIS World Surfactants Conference and Awards for its ...

VANCOUVER, British Columbia, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (US-OTC: SRBCF), also known as Sirona, is excited to share a new milestone in its journey. A ...

Enzo Biochem, a biotechnology company renowned for producing and distributing DNA-based tests designed to identify viral and bacterial diseases, has recently confirmed in a filing with the Securities ...

Enzo Biochem has completed the previously announced transaction to sell substantially all of the assets located in the New York metropolitan region used in the operation of Enzo Clinical Labs to ...

Enzo Biochem has agreed to be acquired by Battery Ventures for $0.70 per share, pending shareholder approval. Enzo Biochem, Inc. announced that it has entered into a merger agreement with Battery ...

Enzo Biochem reported a revenue decline of 20% in Q1 2024, alongside strategic leadership changes and a special cash dividend. Enzo Biochem, Inc. announced its financial results for the first quarter ...

United States Patent and Trademark office will consider claim from Enzo Biochem on patent rights covering seminal biotechnolgy research technique for automated DNA ...